Inspire Medical Systems (INSP) Current Leases (2021 - 2022)

Inspire Medical Systems' (INSP) quarterly Current Leases came in at $1.3 million in Q4 2022, up 328.21% year-on-year from $312000.0 in Q4 2021, and up 328.21% quarter-over-quarter from $312000.0 in Q4 2021.

Inspire Medical Systems (INSP) Current Leases (2021 - 2022) Analysis & Trends

Inspire Medical Systems has disclosed Current Leases across 2 years of filings, most recently posting $1.3 million for Q4 2022.

  • Current Leases for Q4 2022 came in at $1.3 million, up 328.21% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.3 million (up 328.21% YoY), and the FY2022 annual result was $1.3 million, up 328.21% from the prior year.
  • Current Leases came in at $1.3 million for Q4 2022 at Inspire Medical Systems, up from $312000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.3 million in Q4 2022 to a low of $312000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 Inspire Medical Systems 1.22 Bn 933.64 Mn 176.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 1.34 Mn
Dec 31, 2021 312,000.00